Abstract
Therapeutic hypothermia (TH) is standard care for term neonates with moderate to severe hypoxic-ischemic encephalopathy (HIE), but its use in preterm infants 33–35 weeks’ gestational age (GA) remains controversial. This review article summarizes the biological rationale, clinical evidence, and real-world experience supporting or challenging TH in this population. Preclinical models show neuroprotective effects of TH at developmental stages equivalent to late preterm infants. Retrospective studies suggest feasibility but report higher complication rates, particularly at 34 weeks. We critically evaluate the only randomized controlled trial (RCT) to date, which reported no benefit and possible harm with TH in 33–35 weeks’ GA infants. However, this study had important limitations, including baseline imbalances, limited stratification by GA and encephalopathy severity, and lack of neuroimaging or EEG data. A recent international survey of 88 centers reveals heterogeneous practices, with many continuing TH at 34–35 weeks’ GA despite the trial’s findings. Real-world experience from 22 centers shows lower mortality than reported in the RCT. TH may remain appropriate for select 35 weeks’ GA infants, but routine use in 34 weeks’ GA and earlier infants should be limited to research settings. Future studies should stratify by GA and include standardized neurological assessments to inform practice.
Impact of This Review
-
Summarizes preclinical and retrospective clinical data supporting the biological plausibility and feasibility of therapeutic hypothermia (TH) in late preterm infants.
-
Critically examines the limitations of the only RCT of TH in this population and explains why its findings should not be generalized to all 33–35 weeks’ GA infants.
-
Highlights real-world evidence showing lower mortality and supports continued TH use at 35 weeks’ GA while urging caution at 34 weeks or below pending further data.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Jacobs, S. E. et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Ddatabase Syst. Rev. 1, CD003311 (2013).
Committee on Fetus and Newborn. Hypothermia and neonatal encephalopathy. Pediatrics 133, 1146–1150 (2014).
Falck, M. et al. Hypothermic neuronal rescue from infection-sensitised hypoxic-ischaemic brain injury is pathogen dependent. Dev. Neurosci. 39, 238–247 (2017).
Bennet, L. et al. The effect of cerebral hypothermia on white and grey matter injury induced by severe hypoxia in preterm fetal sheep. J. Physiol. 578, 491–506 (2007).
Barrett, R. D. et al. Destruction and reconstruction: hypoxia and the developing brain. Birth Defects Res. Part C Embryo Today 81, 163–176 (2007).
Wassink, G. et al. Hypothermic neuroprotection is associated with recovery of spectral edge frequency after asphyxia in preterm fetal sheep. Stroke 46, 585–587 (2015).
Rao, R. et al. Safety and short-term outcomes of therapeutic hypothermia in preterm neonates 34-35 weeks gestational age with hypoxic-ischemic encephalopathy. J. Pediatr. 183, 37–42 (2017).
Herrera, T. I. et al. Outcomes of preterm infants treated with hypothermia for hypoxic-ischemic encephalopathy. Early Hum. Dev. 125, 1–7 (2018).
Lademann, H., Abshagen, K., Janning, A., Däbritz, J. & Olbertz, D. Long-term outcome after asphyxia and therapeutic hypothermia in late preterm infants: a pilot study. Healthcare 9, 994 (2021).
Kim, S. H., El-Shibiny, H., Inder, T. & El-Dib, M. Therapeutic hypothermia for preterm infants 34-35 weeks gestational age with neonatal encephalopathy. J. Perinatol. 44, 528–531 (2024).
Moran, P., Sullivan, K., Zanelli, S. A. & Burnsed, J. Single-center experience with therapeutic hypothermia for hypoxic-ischemic encephalopathy in infants with <36 weeks’ gestation. Am. J. Perinatol. 41, 1680–1687 (2024).
Faix, R. G. et al. Whole-body hypothermia for neonatal encephalopathy in preterm infants 33 to 35 weeks’ gestation: a randomized clinical trial. JAMA Pediatr. 179, 396–406 (2025).
El-Dib, M. & Inder, T. Data and analysis concerns in trial of whole-body hypothermia for neonatal encephalopathy in preterm infants. JAMA Pediatr. 179, 925 (2025).
Groenendaal, F. Data and analysis concerns in trial whole-body hypothermia for neonatal encephalopathy in preterm infants. JAMA Pediatr. 179, 924 (2025).
Faix, R. G., Laptook, A. R. & Shankaran, S. Data and analysis concerns in trial of whole-body hypothermia for neonatal encephalopathy in preterm infants-reply. JAMA Pediatr. 179, 925–926 (2025).
Gunn, A. J. & Bennet, L. Brain cooling for preterm infants. Clin. Perinatol. 35, 735–748 (2008).
Wood, T. et al. Rectal temperature in the first five hours after hypoxia-ischemia critically affects neuropathological outcomes in neonatal rats. Pediatr. Res. 83, 536–544 (2018).
Sabir, H. et al. Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial. Sci. Rep. 13, 9467 (2023).
Roca, L. P., Fontalvo-Acosta, M., Aldecoa-Bilbao, V. & Alarcón, A. Therapeutic hypothermia in preterm infants under 36 weeks: Case series on outcomes and brain MRI findings. Eur. J. Pediatr. 184, 113 (2025).
Binet, L. et al. Effect of gestational age on cerebral lesions in neonatal encephalopathy. Arch. Dis. Child Fetal Neonatal. Ed. 109, 562–568 (2024).
Pavel, A. M. et al. Temporal evolution of electrographic seizures in newborn infants with hypoxic-ischaemic encephalopathy requiring therapeutic hypothermia: a secondary analysis of the anser studies. Lancet Child Adolesc. Health 8, 214–224 (2024).
Raghu, K. et al. Prognostic indicators of reorientation of care in perinatal hypoxic-ischemic encephalopathy spectrum. J. Pediatr. 276, 114273 (2025).
Natarajan, G. et al. Withdrawal of life-support in neonatal hypoxic-ischemic encephalopathy. Pediatr. Neurol. 91, 20–26 (2019).
Gubler, D. F. L. et al. Redirection of care for neonates with hypoxic-ischemic encephalopathy receiving therapeutic hypothermia. J. Clin. Med. 14, 317 (2025).
Parmentier, C. E. J. et al. Brain MRI Injury patterns across gestational age among preterm infants with perinatal asphyxia. Neonatology 121, 616–626 (2024).
Glass, H. C. et al. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J. Pediatr. 155, 318–323 (2009).
Kharoshankaya, L. et al. Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Dev. Med. Child Neurol. 58, 1242–1248 (2016).
Author information
Authors and Affiliations
Contributions
Mohamed El-Dib conceptualized the review and drafted the initial manuscript. All authors critically reviewed the content, contributed to manuscript revisions, and approved the final version for submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
El-Dib, M., Abdelgadir, D., Ahmad, K.A. et al. Benefits and risks of therapeutic hypothermia for hypoxic-ischemic encephalopathy in late preterm infants. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04428-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41390-025-04428-9
